| Literature DB >> 36028631 |
Hsin-Ya Tang1, Wang-Sheng Ko2, Yuan-Horng Yan3, Su-Chen Yu4, Ya-Ling Chiou5.
Abstract
The nurses work long hours and in various shifts, and often accompanied by depression, fatigue, and sleep disorders. Many studies have found that 25 hydroxyvitamin D (25(OH)D) is related to mental health. We aimed to investigate the relationship between depression, sleep problems, fatigue, and serum 25(OH)D levels in shift nurses. We recruited 34 day-shift, 30 evening-shift and 31 night-shift nurses. The Beck Depression Inventory II (BDI-II), Numerical Rating Scale and General Sleep Disturbance Scale to evaluate the levels of depression, sleep problems, fatigue. Blood samples (20 ml) were collected under a fasting state to determine basic biochemistry and inflammatory parameters. In central of Taiwan, approximately 96.1% of shift nurses had deficient (< 20 ng/ml) (45 females and 1 male) and inadequate (20-29 ng/ml) (39 females and 2 male) 25(OH)D levels. Approximately 84.2% of shift nurses experienced fatigue. In sleep disturbance, night-shift nurses experienced significantly more severe sleep disturbance than day-shift and evening-shift nurses. However, no significant correlation was observed between 25(OH)D levels and mental health when the 25(OH)D level was categorized. 25(OH)D deficiency, sleep disturbance, depression, and fatigue were common in shift female nurses, but it was not possible to demonstrate the impact of 25(OH)D deficiency on the mental health of shift nurses in Taiwan.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36028631 PMCID: PMC9418151 DOI: 10.1038/s41598-022-18721-8
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Figure 1Flowchart for collecting subjects.
Participant characteristics of three shift Nursing Staffs.
| Variables | Shift | |||
|---|---|---|---|---|
| Day (n = 34) | Evening (n = 30) | Night (n = 31) | ||
| Female | 32 (94.1%) | 30 (100%) | 30 (96.8%) | 0.772 |
| Male | 2 (5.9%) | 0 (0.0%) | 1 (3.2%) | |
| Age | 36.5 (31.8–39.3) | 25 (23.0–28.5) | 25 (23.0–30.0) | < 0.001*§¥ |
| BMI (kg/m2) | 21.9 (20.2–23.5) | 19.9 (18.4–22.4) | 21.1 (19.4–23.4) | 0.183 |
| Single | 9 (26.5%) | 27 (90%) | 28 (90.3%) | < 0.001* |
| Married | 25 (73.5%) | 3 (10.0%) | 3 (9.7%) | |
| Ward | 21 (61.8%) | 20 (66.7%) | 14 (45.2%) | 0.702 |
| MICU | 4 (11.8%) | 2 (6.7%) | 4 (12.9%) | |
| SICU | 7 (20.6%) | 7 (23.3%) | 10 (32.3%) | |
| ER | 2 (5.9%) | 1 (3.3%) | 3 (9.7%) | |
| Less than half a year | 5 (14.7%) | 19 (63.3%) | 12 (38.7%) | < 0.001*c |
| Seven months to one year | 2 (5.9%) | 1 (3.3%) | 6 (19.4%) | |
| More than a year | 27 (79.4%) | 10 (33.3%) | 13 (41.9%) | |
| Five-year junior college | 7 (20.6%) | 10 (33.3%) | 9 (29.0%) | 0.733c |
| Two-year college of technology | 8 (23.5%) | 4 (13.3%) | 5 (16.1%) | |
| University or above | 19 (55.9%) | 16 (53.3%) | 17 (54.8%) | |
BMI, body mass index; MICU, Medical Intensive Care Unit; SICU, surgical intensive care unit; ER, emergency room.
*p-value < 0.05(§Day shift v.s. evening shift; ₤ evening shift v.s. night shift; ¥Day shift v.s. night shift). The power after calculation and analysis after the event: the number of subjects is 95 (n = 95), and the ANOVA test is carried out in three groups, and the calculated power is 0.6550386.
aData were continuous and presented as mean ± SD using ANOVA, The Tukey–Kramer test was performed for the post hoc multiple of ANOVA;
bData were continuous and presented as median (IQR) using Kruskal–Wallis test, The Dunn test was performed for the post hoc multiple of Kruskal–Wallis test;
cData were categorical and presented as n (%) using Fisher's exact test;
dData were categorical and presented as n (%) using chi-squared test.
Participant biochemistry of three class shift nurses.
| Variables | Shifts | |||
|---|---|---|---|---|
| Day (n = 34) | Evening (n = 30) | Night (n = 31) | ||
| WBC (103/μl) | 5.3 (4.6–6.2) | 7.3 (6.2–8.6) | 6.0 (5.3–8.0) | < 0.001*§b |
| RBC (103/μl) | 4.7 (4.5–5.0) | 4.8 (4.5–4.9) | 4.7 (4.4–5.1) | 0.995b |
| Hb (gm %) | 13.5 (12.6–14.0) | 13.5 (12.8–14.1) | 13.4 (12.4–14.4) | 0.707b |
| Platelet (1000/μl) | 292.4 ± 78.6 | 307.8 ± 65.5 | 282.9 ± 67.8 | 0.391a |
| Triglyceride (mg/dl) | 74.0 (47.0–96.8) | 71.0 (55.5–92.3) | 69.0 (54.0–94.0) | 0.920b |
| Total Cholesterol (mg/dl) | 173.0 (145.8–194.3) | 176.0 (165.2–214.8) | 184.0 (166.0–196.0) | 0.098b |
| AST (U/l) | 17.5 (15.8–22.0) | 17.0 (15.0–21.0) | 17.0 (15.0–19.0) | 0.716b |
| ALT (U/l) | 12.0 (9.0–16.0) | 10.5 (8.8–16.0) | 14.0 (11.0–15.0) | 0.172b |
| Albumin (mg/dl) | 4.6 (4.5–4.8) | 4.8 (4.5–4.9) | 4.7 (4.5–4.9) | 0.444b |
| CRP (mg/dl) | 0.0 (0.0–0.1) | 0.0 (0.0–0.1) | 0.0 (0.0–0.1) | 0.575b |
| Ferritin (ng/ml) | 43.3 (17.2–76.9) | 49.5 (25.0–95.1) | 39.4 (23.8–62.7) | 0.684b |
| serum iron (μg/dl) | 77.5 (63.0–123.3) | 94.0 (60.8–122.3) | 87.0 (63.0–106.0) | 0.683b |
| TIBC (μg/dl) | 319.0 (285.0–363.5) | 311.0 (294.0–355.5) | 317.0 (282.0–380.0) | 0.853b |
| 25(OH)D (ng/ml) | 21.1 ± 6.2 | 21.3 ± 6.9 | 20.1 ± 4.7 | 0.730a |
| IL-6 (pg/ml) | 0.0 (0.0–0.0) | 0.0 (0.0–0.0) | 0.0 (0.0–0.0) | 0.966b |
| TNF-α (pg/ml) | 0.1 (0.0–10.4) | 3.3 (0.0–13.7) | 7.9 (0.2–21.1) | 0.051b |
| IL-8 (pg/ml) | 1.4 (0.8–2.1) | 1.2 (0.7–2.2) | 1.9 (0.9–2.8) | 0.394b |
| IFN-γ (pg/ml) | 2.6 (0.0–10.8) | 4.8 (0.2–18.9) | 4.4 (0.8–19.2) | 0.679b |
WBC, white blood cell count; RBC, red blood cells; Hb, hemoglobin; AST, aspartate aminotransferase; ALT, alanine aminotransferase; CRP, C-Reactive Protein; TIBC, total iron binding capacity; IL-6, interleukin-6; TNF-α, tumor necrosis factor-α; IL-8, interleukin-8; IFN-γ, interferon-γ.
*p-value < 0.05(§Day shift v.s. evening shift; ₤ evening shift v.s. night shift; ¥Day shift v.s. night shift). The power after calculation and analysis after the event: the number of subjects is 95 (n = 95), and the ANOVA test is carried out in three groups, and the calculated power is 0.6550386.
aData were continuous and presented as mean ± SD using ANOVA, The Tukey–Kramer test was performed for the post hoc multiple of ANOVA.
bData were continuous and presented as median (IQR) using Kruskal–Wallis test, The Dunn test was performed for the post hoc multiple of Kruskal–Wallis test.
The characteristics of three class shift nurses according to 25(OH)D3 concentrations.
| Variables | Serm 25(OH)D3, ng/ml | |||
|---|---|---|---|---|
| < 20 (n = 46) | 20–29 (n = 41) | ≧30 (n = 8) | ||
| Day | 15(32.6%) | 16(39.0%) | 3(37.5%) | 0.186c |
| Evening | 13(28.3%) | 12(29.3%) | 5(62.5%) | |
| Night | 18(39.1%) | 13(31.7%) | 0(0.0%) | |
| Female | 45(97.8%) | 39(95.1%) | 8(100.0%) | 0.693c |
| Male | 1(2.2%) | 2(4.9%) | 0(0.0%) | |
| Age | 28.0(23.0–36.0) | 29.0(24.0–36.5) | 28.0(34.3–31.5) | 0.532b |
| BMI (kg/m2) | 21.1(19.4–22.9) | 21.1(19.7–25.5) | 19.3(18.4–20.1) | 0.133b |
| Single | 33(71.7%) | 26(63.4%) | 5(62.5%) | 0.678d |
| Married | 13(28.3%) | 15(36.6%) | 3(37.5%) | |
| Ward | 26(56.5%) | 24(58.5%) | 5(62.5%) | 0.996c |
| MICU | 5(10.9%) | 4(9.8%) | 1(12.5%) | |
| SUCU | 11(23.9%) | 11(26.8%) | 2(25.0%) | |
| ER | 4(8.7%) | 2(4.9%) | 0(0.0%) | |
| Less than half a year | 18(39.1%) | 14(34.1%) | 4(50.0%) | 0.081c |
| Seven months to one year | 1(2.2%) | 8(19.5%) | 0(0.0%) | |
| More than a year | 27(58.7%) | 19(46.3%) | 4(50.0%) | |
| Five-year junior college | 14(30.4%) | 8(19.5%) | 4(50.0%) | 0.652c |
| Two-year college of technology | 12(26.1%) | 5(12.2%) | 0(0.0%) | |
| University or above | 20(43.5%) | 28(68.3%) | 4(50.0%) | |
BMI, body mass index; MICU, Medical Intensive Care Unit; SICU, surgical intensive care unit; ER, emergency room.
*p-value < 0.05. The power after calculation and analysis after the event: the number of subjects is 95 (n = 95), and the ANOVA test is carried out in three groups, and the calculated power is 0.6550386.
aData were continuous and presented as mean ± SD using ANOVA.
bData were continuous and presented as median (IQR) using Kruskal–Wallis test.
cData were categorical and presented as n (%) using Fisher's exact test.
dData were categorical and presented as n (%) using chi-squared test.
Participant biochemistry according to 25(OH)D3 concentrations.
| Variables | Serum 25(OH)D3, ng/ml | |||
|---|---|---|---|---|
| < 20 (n = 46) | 20–29 (n = 41) | ≧ 30 (n = 8) | ||
| WBC (103/μl) | 6.2 ± 1.6 | 6.8 ± 1.9 | 6.3 ± 1.5 | 0.303a |
| RBC (103/μl) | 4.7 (4.4–4.9) | 4.8 (4.5–5.0) | 4.7 (4.5–5.0) | 0.132b |
| Hb (gm %) | 13.2 (12.4–14.1) | 13.6 (12.8–14.2) | 13.6 (12.9–13.8) | 0.389b |
| Platelet (1000/μl) | 289.0 ± 68.3 | 295.3 ± 77.5 | 318.3 ± 52.6 | 0.561a |
| Triglyceride (mg/dl) | 69.0 (51.0–92.5) | 76.0 (54.5–97.5) | 63.5 (53.0–86.5) | 0.624b |
| Total Cholesterol (mg/dl) | 183.1 ± 27.3 | 180.5 ± 30.0 | 170.1 ± 32.5 | 0.505a |
| AST (U/L) | 17.0 (16.0–21.0) | 17.0 (15.0–19.0) | 18.5 (15.3–24.8) | 0.541b |
| ALT (U/L) | 13.0 (9.8–16.5) | 13.0 (10.0–15.5) | 9.5 (8.3–21.0) | 0.475b |
| Albumin(mg/dl) | 4.7 ± 0.3 | 4.7 ± 0.3 | 4.8 ± 0.3 | 0.414a |
| CRP (mg/dl) | 0.0 (0.0–0.1) | 0.0 (0.0–0.1) | 0.1 (0.0–0.1) | 0.602b |
| Ferritin (ng/ml) | 34.5 (20.7–62.9) | 52.3 (25.4–73.3) | 66.9 (20.8–130.3) | 0.230b |
| serum iron (μg/dl) | 94.2 ± 40.1 | 86.7 ± 36.7 | 100.4 ± 47.5 | 0.539b |
| TIBC (μg/dl) | 319.5 (292.5–365.0) | 315.0 (283.5–364.5) | 315.0 (293.0–340.0) | 0.960a |
| IL-6 (pg/ml) | 0.0 (0.0–0.0) | 0.0 (0.0–0.0) | 0.0 (0.0–0.0) | 0.429b |
| TNF-α (pg/ml) | 3.0 (0.0–17.5) | 2.6 (0.0–14.9) | 4.8 (0.0–15.6) | 0.957b |
| IL-8 (pg/ml) | 1.4 (0.8–2.8) | 1.3 (0.7–2.0) | 1.6 (0.6–3.4) | 0.748b |
| IFN-γ (pg/ml) | 2.3 (0.3–15.3) | 4.5 (0.1–14.5) | 6.4 (1.3–16.0) | 0.757b |
WBC, white blood cell count; RBC, red blood cells; Hb, hemoglobin; AST, aspartate aminotransferase; ALT, alanine aminotransferase; CRP, C-Reactive Protein; TIBC, total iron binding capacity; IL-6, Interleukin-6; TNF-α, tumor necrosis factor-α; IL-8, interleukin-8; IFN-γ, interferon-γ.
*p-value < 0.05. The power after calculation and analysis after the event: the number of subjects is 95 (n = 95), and the ANOVA test is carried out in three groups, and the calculated power is 0.6550386.
aData were continuous and presented as mean ± SD using ANOVA.
bData were continuous and presented as median (IQR) using Kruskal–Wallis test.
Participant questionnaire score of three class shift nurses.
| Variables | Shift | |||
|---|---|---|---|---|
| Day (n = 34) | Evening (n = 30) | Night (n = 31) | ||
| Total score | 10.5 (7.0–17.3) | 12.5 (7.8–19.3) | 16.0 (12.0–19.0) | 0.245b |
| Normal | 20 (58.8%) | 16 (53.3%) | 11 (35.5%) | 0.572c |
| Mild depression | 9 (26.5%) | 7 (23.3%) | 13 (41.9%) | |
| Moderate depression | 3 (8.8%) | 4 (13.3%) | 4 (12.9%) | |
| Severe depression | 2 (5.9%) | 3 (10.0%) | 3 (9.7%) | |
| Total score | 34.0 ± 13.0 | 37.9 ± 12.7 | 39.0 ± 15.6 | 0.302a |
| Average score | 4.9 ± 1.9 | 5.4 ± 1.8 | 5.6 ± 2.2 | 0.302a |
| Fatigue | 27 (33.8%) | 26 (32.5%) | 27 (33.8%) | 0.643c |
| Non-fatigue | 7 (46.7%) | 4 (26.7%) | 4 (26.7%) | |
| Total score | 46.0 ± 12.8 | 46.4 ± 13.1 | 53.3 ± 12.5 | 0.043*₤¥a |
| Average score | 3.1 ± 0.9 | 3.1 ± 0.9 | 3.6 ± 0.8 | 0.043*₤¥a |
| Sleep disorder | 25 (33.3%) | 23 (30.7%) | 27 (36.0%) | 0.38d |
| Non-sleep disorder | 9 (45.0%) | 7 (35.0%) | 4 (20.0%) | |
BDI-II, Beck Depression Inventory II; NRS-F, Numerical Rating Scale for Fatigue; GSDS, General Sleep Disturbance Scale.
*p-value < 0.05(§Day shift v.s. evening shift; ₤ evening shift v.s. night shift; ¥Day shift v.s. night shift). The power after calculation and analysis after the event: the number of subjects is 95 (n = 95), and the ANOVA test is carried out in three groups, and the calculated power is 0.6550386.
aData were continuous and presented as mean ± SD using ANOVA, The Tukey–Kramer test was performed for the post hoc multiple of ANOVA.
bData were continuous and presented as median (IQR) using Kruskal–Wallis test, The Dunn test was performed for the post hoc multiple of Kruskal–Wallis test.
cData were categorical and presented as n (%) using Fisher's exact test.
dData were categorical and presented as n (%) using chi-squared test.
Participant questionnaire score according to 25(OH)D3 concentrations.
| Variables | Serum 25(OH)D3, ng/ml | |||
|---|---|---|---|---|
| < 20 (n = 46) | 20–29 (n = 41) | ≧ 30 (n = 8) | ||
| Total score | 12.5 (7.0–19.0) | 15.0 (8.5–19.0) | 14.0 (9.0–31.3) | 0.561b |
| Normal | 26 (56.5%) | 17 (41.5%) | 4 (50%) | 0.402c |
| Mild depression | 11 (23.9%) | 16 (39.0%) | 2 (25.0%) | |
| Moderate depression | 6 (13.0%) | 5 (12.2%) | 0 (0.0%) | |
| Severe depression | 3 (6.5%) | 3 (7.3%) | 2 (25.0%) | |
| Total score | 38.4 ± 13.6 | 35.2 ± 13.8 | 36.3 ± 16.4 | 0.577a |
| Average score | 5.5 ± 1.9 | 5.0 ± 2.0 | 5.2 ± 2.3 | 0.577a |
| Fatigue | 42 (52.5%) | 32 (40%) | 6 (7.5%) | 0.181d |
| Non-fatigue | 4 (26.7%) | 9 (60.0%) | 2 (13.2%) | |
| Total score | 50.0 ± 13.8 | 47.1 ± 12.5 | 46.9 ± 12.4 | 0.546a |
| Average score | 3.3 ± 0.9 | 3.1 ± 0.8 | 3.1 ± 0.8 | 0.546a |
| Sleep disorder | 38 (50.7%) | 31 (41.3%) | 6 (8.0%) | 0.697d |
| Non-sleep disorder | 8 (40.0%) | 10 (50.0%) | 2 (10.0%) | |
BDI-II, Beck Depression Inventory II; NRS-F, Numerical Rating Scale for Fatigue; GSDS, General Sleep Disturbance Scale.
*p-value < 0.05. The power after calculation and analysis after the event: the number of subjects is 95 (n = 95), and the ANOVA test is carried out in three groups, and the calculated power is 0.6550386.
aData were continuous and presented as mean ± SD using ANOVA.
bData were continuous and presented as median (IQR) using Kruskal–Wallis test.
cData were categorical and presented as n (%) using Fisher's exact test.
dData were categorical and presented as n (%) using chi-squared test.